[Treatment of deep venous thrombosis in congenital antithrombin III deficiency with low molecular weight heparin]

J F Schved; J C Gris; A Dubois; J Jourdan

doi:10.1016/s0248-8663(88)80125-5

[Treatment of deep venous thrombosis in congenital antithrombin III deficiency with low molecular weight heparin]

Rev Med Interne. 1988 Mar-Apr;9(2):217-20. doi: 10.1016/s0248-8663(88)80125-5.

[Article in French]

Authors

J F Schved¹, J C Gris, A Dubois, J Jourdan

Affiliation

¹ Laboratoire d'hématologie et immunologie, centre hospitalier régional et universitaire de Nimes.

PMID: 2843978
DOI: 10.1016/s0248-8663(88)80125-5

Abstract

A 19-year old male patient with hereditary antithrombin III type I deficiency was admitted for thrombosis of the right iliac, femoral and popliteal veins. Treatment with a low molecular weight heparin resulted in recanalization of the veins confirmed by phlebography. After two weeks of treatment, the drug was replaced by another low molecular weight heparin and this was followed, 3 weeks later, by a documented relapse of thrombosis.

Publication types

Case Reports
English Abstract

MeSH terms

Adult
Antithrombin III Deficiency*
Heparin, Low-Molecular-Weight / administration & dosage
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Male
Recurrence
Thrombophlebitis / drug therapy*

Substances

Heparin, Low-Molecular-Weight